Glutamate antagonists: deadly liaisons with cancer.
Cavalheiro
E A
EA
Neurologia Experimental, Departamento de Neurologia e Neurocirurgia, Escola Paulista de Medicina/Universidade Federal de São Paulo, Rua Botucatu 862, 04023 São Paulo, SP, Brazil. esper.nexp@epm.br
Olney
J W
JW
D000818:Animals; D014151:Anti-Anxiety Agents / Q000494:pharmacology; D000970:Antineoplastic Agents / Q000494:pharmacology*; D001569:Benzodiazepines; D002465:Cell Movement / Q000187:drug effects; D016291:Dizocilpine Maleate / Q000494:pharmacology; D004357:Drug Synergism; D018691:Excitatory Amino Acid Antagonists / Q000494:pharmacology*; D006131:Growth Inhibitors / Q000494:pharmacology; D006801:Humans; D009369:Neoplasms / Q000503:physiopathology; D018091:Receptors, AMPA / Q000037:antagonists & inhibitors; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors
D014151:Anti-Anxiety Agents; D000970:Antineoplastic Agents; D018691:Excitatory Amino Acid Antagonists; D006131:Growth Inhibitors; D018091:Receptors, AMPA; D016194:Receptors, N-Methyl-D-Aspartate; C061950:GYKI 52466; D001569:Benzodiazepines; D016291:Dizocilpine Maleate